| |
| |
|
| Insider
Information: |
Carroll Jill |
| Relationship: |
|
| City: |
Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
3,468,746 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$783,106 |
|
|
| Total
Shares |
3,468,746 |
|
|
| Total
Value |
$783,106 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Applied Genetic Technologies Corp |
AGTC |
Director, 10% Owner |
2014-04-01 |
0 |
2014-04-01 |
1,989,598 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
Director, 10% Owner |
2020-07-21 |
0 |
2021-04-01 |
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
|
2022-02-08 |
0 |
2024-03-21 |
1,479,148 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACLX |
Arcellx, Inc. |
|
– • – |
2024-03-21 |
4 |
S |
$70.55 |
$35,575,755 |
I/I |
(504,263) |
1,479,148 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-12-14 |
4 |
S |
$49.13 |
$24,774,441 |
I/I |
(504,263) |
1,983,411 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-06-01 |
4 |
S |
$44.35 |
$1,133,317 |
I/I |
(25,556) |
2,487,674 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-05-31 |
4 |
S |
$41.50 |
$13,079,306 |
I/I |
(315,164) |
2,513,230 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2023-05-11 |
4 |
S |
$45.00 |
$28,736,223 |
I/I |
(638,417) |
2,828,394 |
0 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2022-02-08 |
4 |
B |
$15.00 |
$25,000,005 |
I/I |
1,666,667 |
2,033,196 |
2.1 |
- |
|
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
3,833,340 |
433,196 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2021-04-01 |
4 |
D |
$60.00 |
$340,453,260 |
I/I |
(5,674,221) |
0 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$6,499,998 |
I/I |
361,111 |
2,248,304 |
2.25 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,887,193 |
1,887,193 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • • |
2014-04-01 |
4 |
B |
$12.00 |
$1,245,144 |
I/I |
103,762 |
1,989,598 |
2.25 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • • |
2014-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,885,836 |
1,885,836 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
